NDI Medical, LLC, a venture and commercialization firm that funds and develops innovative neurodevice technologies, has launched its next portfolio company, Deep Brain Innovations, LLC (DBI). DBI will commercialize its groundbreaking technology that is designed to optimize deep brain stimulation (DBS) therapy for patients with Parkinson’s disease. Currently available DBS therapy is effective in treating Parkinson’s disease and generates more than $275 million in annual sales. However, NDI has validated an opportunity to further expand this market with a revolutionary approach to DBS.
Click for full article